Embassy Developments Q3 loss widens; auditor flags NCLAT insolvency matter

Emphasis Of MatterPat NegativeRevenue DeclineExceptional ItemResults View source PDF Explain this filing

EMBDL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.1%Reaction day

₹67.73

prior close

₹65.32

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%-6.1% vs market

Residential Commercial Projects peers, median of 61sector+0.6%-5.7% vs sector

On the reaction day the stock moved 6.1 pts less than Nifty Microcap 250 and 5.7 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-0.2

15m

-0.0

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.1+1.0-6.1+0.6-5.7

Next day

-5.3+0.5-5.8+0.2-5.5

-6.2-0.0-6.2-1.2-5.1

-5.1-1.5-3.6-2.9-2.1

-6.7-2.2-4.5-3.1-3.5

-5.2-1.2-4.0-2.9-2.3

-7.7-2.4-5.4-3.8-3.9

15d

-15.3-8.8-6.4-10.6-4.6

-18.9-8.3-10.6-12.8-6.2

—-3.5—-8.7—

+6.9+6.4+0.5-3.0+9.9

UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Embassy Developments posted weak Q3 FY26 results. Standalone revenue dropped to Rs 405.22M from Rs 2,948.33M YoY with a loss of Rs 739.63M. Consolidated Q3 loss was Rs 2,337M against profit earlier. Nine-month consolidated loss stood at Rs 5,520M versus a profit of Rs 706M last year. Auditor issued unmodified review but added an emphasis of matter on the ongoing NCLAT insolvency proceedings linked to an old corporate guarantee. Prior year figures are not comparable due to reverse merger accounting.

Likely market impact

Widening losses and unresolved NCLAT insolvency case may weigh on the stock. Next hearing Feb 19. Prior year figures not comparable due to reverse merger.